Ventec Life Systems, Inc., a wholly owned subsidiary of React Health Holdings, has acquired the assets of the Invacare Respiratory Product line following Invacare’s exit in November of 2022. “With this acquisition, React Health is well-positioned to continue to support the end-to-end care of patients with cardiology, sleep, and respiratory […]
Sleep Disorders
ITC Judge Rules Apple Violated Masimo Pulse Oximeter Patent
A United States Administrative Law Judge in Washington, D.C. ruled that Apple Inc. violated Section 337 of the Tariff Act of 1930 as amended, by importing and selling within the United States certain Apple Watches with light-based pulse oximetry functionality and components, which infringe one of Masimo’s pulse oximeter patents. […]
Philips PAP Recall December 2022 Update
Program update As we approach the end of 2022, we expect to complete around 90% of the production this year for the delivery of replacement devices to patients. Patients who are still waiting to receive their replacement device can expect to continue hearing from us as we work through some […]
React Health’s Luna G3 Bilevel S/T 30VT Approved for NIV
React Health has announced 510(k) clearance by the U.S. Food and Drug Administration for the Luna G3 Bilevel S/T 30VT as a non-invasive ventilator. This expands the utilization of the device beyond the sleep-disordered breathing space into management of chronic respiratory conditions. “We are pleased that the FDA has approved […]
CAIRE to Acquire MGC Diagnostics Holdings, Inc.
CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., will acquire St. Paul, Minnesota-based MGC Diagnostics Holdings, Inc. (MGC). MGC designs, develops, manufactures, and markets non-invasive cardiorespiratory diagnostic systems, accessories, and consumables for the detection, classification, and management of cardiorespiratory disease. The acquisition will close by the end of […]
AlphaID, First Free Home alpha-1 Genetic Risk Test
Grifols has announced that its AlphaID™ At Home Genetic Health Risk Service, the first-ever free direct-to-consumer program in the U.S. to screen for genetic risk of alpha1-antitrypsin deficiency (alpha-1), has been cleared by the U.S. Food and Drug Administration (FDA). The service, also known as AlphaID™ At Home, is the […]
ndd’s EasyOne Air Spirometer Shines at World’s Largest Freediving Competition
ndd Medical Technologies (ndd), announces the successful deployment of its EasyOne Air portable spirometer for testing lung function at the world’s largest freediving competition, Vertical Blue. In a true test of EasyOne Air’s capabilities in challenging field conditions, the benefits of the portable spirometer shone through, yielding accurate and consistent […]
Medtronic to Spinoff Respiratory and Monitoring Units
Medtronic plc announced its intention to pursue a separation of the company’s combined Patient Monitoring and Respiratory Interventions businesses (“NewCo”), which are part of the company’s Medical Surgical Portfolio. “We are executing on our portfolio management strategy, taking action to create value for Medtronic and our shareholders. This separation will […]
Apnimed OSA Pill Completes Positive Phase 2 Clinical Trials
Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies to treat obstructive sleep apnea (OSA) and related disorders, announced positive topline results from the MARIPOSA Phase 2b trial, an efficacy, safety and dose-finding study of one-month duration. The topline results were positive for the company’s lead candidate for […]
Transcend Micro, World’s Smallest and Lightest CPAP Device
Transcend Inc. recently introduced Transcend Micro, the world’s smallest and lightest portable continuous positive airway pressure (CPAP) device. Weighing under a half pound and measuring less than four inches, Transcend Micro is designed to make it more convenient for people who suffer from Obstructive Sleep Apnea to maintain their sleep […]













